Teriparatide vs risedronate for osteoporosis Reply

David L. Kendler; Piet Geusens; Cristiano A. F. Zerbini; Salvatore Minisola; Fernando Marin

doi:10.1016/S0140-6736(18)30756-6

Teriparatide vs risedronate for osteoporosis Reply

David L. Kendler^*, Piet Geusens, Cristiano A. F. Zerbini, Salvatore Minisola, Fernando Marin

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	1896-1896
Number of pages	1
Journal	Lancet
Volume	391
Issue number	10133
DOIs	https://doi.org/10.1016/S0140-6736(18)30756-6
Publication status	Published - 12 May 2018

Keywords

POSTMENOPAUSAL WOMEN
FRACTURES
ALENDRONATE

Access to Document

10.1016/S0140-6736(18)30756-6

Cite this

@article{ccc6a192d0724021b41eba65c8d99b27,

title = "Teriparatide vs risedronate for osteoporosis Reply",

keywords = "POSTMENOPAUSAL WOMEN, FRACTURES, ALENDRONATE",

author = "Kendler, {David L.} and Piet Geusens and Zerbini, {Cristiano A. F.} and Salvatore Minisola and Fernando Marin",

year = "2018",

month = may,

day = "12",

doi = "10.1016/S0140-6736(18)30756-6",

language = "English",

volume = "391",

pages = "1896--1896",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier Science",

number = "10133",

}

TY - JOUR

T1 - Teriparatide vs risedronate for osteoporosis Reply

AU - Kendler, David L.

AU - Geusens, Piet

AU - Zerbini, Cristiano A. F.

AU - Minisola, Salvatore

AU - Marin, Fernando

PY - 2018/5/12

Y1 - 2018/5/12

KW - POSTMENOPAUSAL WOMEN

KW - FRACTURES

KW - ALENDRONATE

U2 - 10.1016/S0140-6736(18)30756-6

DO - 10.1016/S0140-6736(18)30756-6

M3 - Comment/Letter to the editor

SN - 0140-6736

VL - 391

SP - 1896

EP - 1896

JO - Lancet

JF - Lancet

IS - 10133

ER -